Today
High-Potassium Diets Support Better Mood and Mental Health
Low potassium intake is strongly linked to higher rates of depression and anxiety, making this mineral a key factor in protecting your mental health Large-scale studies from Korea, the U.S., and China all show that people who consume more potassium experience greater emotional st ... Show More
7m 54s
Today
Blockbuster Anticlotting Drug Approved on Flawed Studies
Ticagrelor, a blockbuster anticlotting drug, was approved despite FDA scientists warning it looked less safe and effective than older, cheaper alternatives like clopidogrel The landmark PLATO trial used to secure approval showed U.S. patients had worse outcomes on ticagrelor, yet ... Show More
7m 29s
Apr 2024
617: Health Benefits of Methylene Blue & C60 with Mike Belkowski
Methylene Blue, C60, Mitochondrial Health - Join us in this week's podcast where we sit down with the wonderful Mike Belkowski, founder of BioLight, renowned for developing effective red light therapy panels! Mike introduces us to the concept of the "mitochondrial triad" for enha ... Show More
47m 25s
Jul 2019
Why Dogs Now Play a Big Role in Human Cancer Research
The Cancer Moonshot initiative, launched under the Obama administration, was audacious by design: Supercharge cancer research to encourage innovation, with the mission “to end to cancer as we know it.” Cancer researchers avoid using the word “cure.” From studying cancer at the mo ... Show More
7m 10s
Nov 2024
CAR T Cells and T-Cell Therapies for Cancer
CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott, M ... Show More
18m 22s
May 2025
Measurable residual disease and maintenance therapy in acute myeloid leukemia (AML), stemness and chemotherapy resistance in AML, and effects of babesiosis on red blood cells in sickle cell disease
In this week's episode, we’ll learn more about how measurable residual disease might help guide decisions about post-transplant gilteritinib maintenance in FLT3-ITD acute myeloid leukemia, or AML; how stemness contributes to chemotherapy resistance in AML; and effects of babesios ... Show More
19m 58s